Related Experiment Videos
Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor
Basem S Goueli1, Ralf Janknecht
1Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Oncogene
|September 13, 2003
Summary
Upstream stimulatory factor (USF) 1 and 2 bind to the human telomerase reverse transcriptase (hTERT) promoter. USF1/2 activates hTERT transcription in cancer cells, contributing to cell immortality.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Human telomerase reverse transcriptase (hTERT) upregulation drives cancer cell immortalization.
- The precise mechanisms controlling hTERT transcription remain incompletely understood.
- Previous models implicating Myc/Max in hTERT promoter activation are being re-evaluated.
Purpose of the Study:
- To investigate the role of alternative E-box-binding proteins in regulating hTERT transcription.
- To elucidate the mechanism of hTERT promoter activation in cancer cells.
- To identify key factors involved in cellular immortalization.
Main Methods:
- In vitro and in vivo binding assays to assess protein-DNA interactions.
- Reporter gene assays to measure hTERT promoter activity.
- Co-transfection experiments with coactivators and kinase inhibitors.
Main Results:
- Upstream stimulatory factor (USF) 1 and 2 heterodimers bind strongly to E-boxes in the hTERT promoter.
- Myc/Max complexes do not significantly bind these E-boxes.
- USF1/2 binding is observed in both hTERT-positive and -negative cells, but activation occurs only in hTERT-positive cells.
- hTERT promoter activation by USF1/2 is enhanced by p300 and inhibited by p38-MAP kinase inhibition.
Conclusions:
- USF1/2 plays a critical role in activating hTERT transcription in immortalized cancer cells.
- USF binding to the hTERT promoter is context-dependent, acting as a stimulator in cancer cells and potentially neutral or repressive in normal somatic cells.
- USF1/2 is a key contributor to the acquisition and maintenance of cancer cell immortality.